Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CYRX
CYRX logo

CYRX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cryoport Inc (CYRX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.040
1 Day change
-3.02%
52 Week Range
11.450
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cryoport Inc (CYRX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are mixed, with bearish moving averages and neutral RSI. The financial performance shows revenue growth but significant declines in net income and EPS. Options data suggests low trading sentiment, and there are no recent positive news or catalysts. Given the lack of strong signals and catalysts, holding off on buying is recommended for now.

Technical Analysis

The MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral at 56.487, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 8.088, with resistance at 8.449 and support at 7.727.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data shows a low put-call ratio, indicating minimal bearish sentiment, but the overall volume and activity are very low, suggesting limited trading interest.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
1

Positive Catalysts

  • Gross margin improved slightly by 1.57% YoY.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from insiders or hedge funds. No recent congress trading data.

Financial Performance

In Q4 2025, revenue increased to $45.45M (up 9.64% YoY), but net income dropped to -$13.64M (down 34.01% YoY). EPS declined to -0.27 (down 35.71% YoY), and gross margin improved slightly to 47.77% (up 1.57% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast CYRX stock price to rise
1 Analyst Rating
Wall Street analysts forecast CYRX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.290
sliders
Low
11
Averages
11
High
11
Current: 8.290
sliders
Low
11
Averages
11
High
11
UBS
Buy
maintain
$11
AI Analysis
2025-11-05
Reason
UBS
Price Target
$11
AI Analysis
2025-11-05
maintain
Buy
Reason
UBS raised the firm's price target on Cryoport to $12.50 from $11 and keeps a Buy rating on the shares.
BTIG
NULL -> Buy
maintain
$10 -> $15
2025-09-18
Reason
BTIG
Price Target
$10 -> $15
2025-09-18
maintain
NULL -> Buy
Reason
BTIG raised the firm's price target on Cryoport to $15 from $10 and keeps a Buy rating on the shares. The stock has been under some pressure over the past 2 years, but this is likely due to worries around the Inflation Reduction Act, tariffs, Most Favored Nation, and drug pricing reform risk, and the market appears to be turning the corner, the analyst tells investors in a research note. Cryoport's gross margin and Product revenue growth are also showing good improvement, and the company has well over $400M of cash, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CYRX
Unlock Now

People Also Watch